Studies of Filipino patients with systemic lupus erythematosus: Autoantibody profile of first-degree relatives

Lupus

Volumn 20, Issue 5, 2011, Pages 537-543

  Navarra, S V ^a   Ishimori, M L ^b   Uy, E A ^a   Hamijoyo, L ^a   Sama, J ^c   James, J A ^d   Holers, V M ^e   Weisman, M H ^b  

^a UNIVERSITY OF SANTO TOMAS   (Philippines)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Rheumatology Diagnostics Laboratory   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibody profile; First degree relatives; Systemic Lupus Erythematosus

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CHROMATIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; RO ANTIBODY; THYROID MICROSOME ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; FILIPINO; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RELATIVE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHILIPPINES; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 79955662105     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310385164     Document Type: Article

References (34)

1. Horwitz DA, Gray JD Dubois' Lupus Erythematosus. Wallace DJ Hahn BH, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2007: 133-160.
2. Manzi SM, Stark VE, Ramsey-Goldman R Rheumatology. Weinblatt M Hochberg MC Simon L Weisman MH, ed. Edinburgh: Mosby ; 2003: 1291-1296.
3. McCarty DJ, Manzi S, Medsger Jr, TA, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995 ; 38: 1260-1270
4. Kamen DL, Barron M, Parker TM, et al. Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis Rheum. 2008 ; 58: 1237-1247 (Pubitemid 351705912)
5. Tikly M, Navarra SV. Lupus in the developing world-is it any different?. Best Pract Res Clin Rheumatol. 2008 ; 22: 643-655
6. Navarra SV, Villamin CAC, Baes RP, Pimenta L, Nicdao JL, Bernas GD. Increased frequency of mannose-binding lectin promoter LX haplotype among Filipinos with systemic lupus erythematosus. Lupus. 2007 ; 16: 147-148 (Pubitemid 46347939)
7. Rhodes B, Wong A, Navarra SV, Villamin C, Vyse TJ. Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Genes Immun. 2008 ; 9: 153-160 (Pubitemid 351358920)
8. Eroglu GE, Kohler PF. Familial and systemic lupus erythematosus: the role of genetic and environmental factors. Ann Rheum Dis. 2002 ; 61: 29-31 (Pubitemid 34074835)
9. Harley JB, Kelly JA, Moser KL Rheumatology. Weinblatt M Hochberg MC Simon L Weisman MH, ed. Edinburgh: Mosby ; 2003: 1317-1322.
10. Jarvinen P, Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum. 1994 ; 24: 19-28
11. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992 ; 35: 311-318
12. Larsen RA, Solheim BG. Presence of antinuclear factors (ANTF) in the total populations of relatives and spouses of selected SLE probands. Acta Med Scand. 1972 ; 543: 55-64
13. Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol. 1987 ; 14: 913-921
14. Pollack VE. Antinuclear antibodies in families of patients with SLE. N Eng J Med. 1964 ; 271: 165-171
15. Sato EI, Gabriel A, Masi AT. Systemic lupus erythematosus: a family study of 25 probands. Clin Exp Rheumatol. 1991 ; 9: 455-461
16. Michel M, Johanet C, Meyer O, et al. Familial lupus erythematosus: clinical and immunologic features of 125 multiplex families. Medicine. 2001 ; 80: 153-158 (Pubitemid 32466456)
17. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS. Risk factors for the development of systemic lupus erythematosus: Allergies, infections, and family history. J Clin Epidemiol. 2002 ; 55: 982-989 (Pubitemid 36018862)
18. Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol. 1987 ; 14: 867-869
19. Tan EM, Feltkamp EW, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997 ; 40: 1601-1611 (Pubitemid 27426153)
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1925-1925
21. Shoenfeld Y, Slor H, Shafrir S, et al. Diversity and pattern of inheritance of autoantibodies in families with multiple cases of systemic lupus erythematosus. Ann Rheum Dis. 1992 ; 51: 611-618
22. Laustrup H, Heegaard NH, Voss A, Green A, Lillevang ST, Junker P. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patient: a community based approach. Lupus. 2004 ; 13: 792-799 (Pubitemid 39457441)
23. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
24. Miles S, Isenberg DA. A review of serologic abnormalities in relatives of SLE patients. Lupus. 1993 ; 2: 145-150 (Pubitemid 23225629)
25. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Eng J Med. 2003 ; 349: 1526-1533 (Pubitemid 37255038)
26. Van der Linden MW, Westendorp RG, Zidane M, Meheus L, Huizinga TW. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigen. J Rheumatol. 2001 ; 28: 284-287 (Pubitemid 32165133)
27. Villamin CAC, Navarra SV. Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus. Mod Rheumatol. 2008 ; 18: 161-164
28. Navarra SV, King JO. An overview of clinical manifestations and survival of systemic lupus erythematosus patients in Asia. APLAR J Rheumatol. 2006 ; 9: 336-341 (Pubitemid 44741440)
29. Mok CC, To CH, Ho LY, Yu KL. Incidence and mortality of systemic lupus erythematosus in a Southern Chinese Population 2000-2006. J Rheumatol. 2008 ; 35: 1978-1982
30. Cervera R, Khamashta MA, Font J, et al. European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003 ; 82: 299-308 (Pubitemid 37229465)
31. Arbuckle MR, James JA, Dennis GJ, et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 2003 ; 12: 99-106 (Pubitemid 36240842)
32. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 2005 ; 52: 1138-1147 (Pubitemid 40530121)
33. Abutiban F, Mokkaddam K, Ameen E, Moussa M, Alsaeid K. Comparison between familial and sporadic systemic lupus erythematosus in Kuwaiti patients. Lupus. 2009 ; 18: 86-91
34. Clarke AE, Penrod J, St. Pierre Y, Petri MA, Manzi S, Isenberg DA, et al. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol. 2000 ; 27: 2597-2604